Nevertheless, Wang et al. reported that high LDHA expression was associated with better PFS (18.3 vs. 10.1 months, P=0.005) and overall response rate (72.2% vs. 15.4%, P=0.006) of metastatic colorectal cancer patients receiving first-line chemotherapy [47]. This evidence concerns the gene LDHA and metastatic colorectal cancer.